BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 19724043)

  • 21. Water, sanitation, and hygiene for control of trachoma in Ethiopia (WUHA): a two-arm, parallel-group, cluster-randomised trial.
    Aragie S; Wittberg DM; Tadesse W; Dagnew A; Hailu D; Chernet A; Melo JS; Aiemjoy K; Haile M; Zeru T; Tadesse Z; Gwyn S; Martin DL; Arnold BF; Freeman MC; Nash SD; Callahan EK; Porco TC; Lietman TM; Keenan JD
    Lancet Glob Health; 2022 Jan; 10(1):e87-e95. PubMed ID: 34919861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics for trachoma.
    Evans JR; Solomon AW
    Cochrane Database Syst Rev; 2011 Mar; (3):CD001860. PubMed ID: 21412875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction and return of infectious trachoma in severely affected communities in Ethiopia.
    Lakew T; House J; Hong KC; Yi E; Alemayehu W; Melese M; Zhou Z; Ray K; Chin S; Romero E; Keenan J; Whitcher JP; Gaynor BD; Lietman TM
    PLoS Negl Trop Dis; 2009; 3(2):e376. PubMed ID: 19190781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When the Neighboring Village is Not Treated: Role of Geographic Proximity to Communities Not Receiving Mass Antibiotics for Trachoma.
    Mosenia A; Haile BA; Shiferaw A; Gebresillasie S; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Callahan EK; Zhou Z; Lietman TM; Keenan JD
    Clin Infect Dis; 2023 Mar; 76(6):1038-1042. PubMed ID: 36477547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
    Keenan JD; Ayele B; Gebre T; Moncada J; Stoller NE; Zhou Z; Porco TC; McCulloch CE; Gaynor BD; Emerson PM; Schachter J; Lietman TM
    Clin Infect Dis; 2012 Jan; 54(2):253-6. PubMed ID: 22095569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.
    Melese M; Chidambaram JD; Alemayehu W; Lee DC; Yi EH; Cevallos V; Zhou Z; Donnellan C; Saidel M; Whitcher JP; Gaynor BD; Lietman TM
    JAMA; 2004 Aug; 292(6):721-5. PubMed ID: 15304470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: a cluster randomised trial.
    Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM; Oldenburg CE
    Br J Ophthalmol; 2018 May; 102(5):680-686. PubMed ID: 28893761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
    Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL
    Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
    Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM;
    Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial.
    Liu F; Porco TC; Mkocha HA; Muñoz B; Ray KJ; Bailey RL; Lietman TM; West SK
    Epidemics; 2014 Mar; 6():10-7. PubMed ID: 24593917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of community level treatment and preventative interventions on trachoma prevalence in rural Ethiopia.
    Cumberland P; Edwards T; Hailu G; Harding-Esch E; Andreasen A; Mabey D; Todd J
    Int J Epidemiol; 2008 Jun; 37(3):549-58. PubMed ID: 18356196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin.
    Edwards T; Harding-Esch EM; Hailu G; Andreason A; Mabey DC; Todd J; Cumberland P
    Trop Med Int Health; 2008 Apr; 13(4):556-65. PubMed ID: 18282237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions.
    Keenan JD; See CW; Moncada J; Ayele B; Gebre T; Stoller NE; McCulloch CE; Porco TC; Gaynor BD; Emerson PM; Schachter J; Lietman TM
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):235-40. PubMed ID: 22159017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.
    Skalet AH; Cevallos V; Ayele B; Gebre T; Zhou Z; Jorgensen JH; Zerihun M; Habte D; Assefa Y; Emerson PM; Gaynor BD; Porco TC; Lietman TM; Keenan JD
    PLoS Med; 2010 Dec; 7(12):e1000377. PubMed ID: 21179434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
    Harding-Esch EM; Sillah A; Edwards T; Burr SE; Hart JD; Joof H; Laye M; Makalo P; Manjang A; Molina S; Sarr-Sissoho I; Quinn TC; Lietman T; Holland MJ; Mabey D; West SK; Bailey R;
    PLoS Negl Trop Dis; 2013; 7(6):e2115. PubMed ID: 23785525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso: The CHAT Randomized Clinical Trial.
    Oldenburg CE; Ouattara M; Bountogo M; Boudo V; Ouedraogo T; Compaoré G; Dah C; Zakane A; Coulibaly B; Bagagnan C; Hu H; O'Brien KS; Nyatigo F; Keenan JD; Doan T; Porco TC; Arnold BF; Lebas E; Sié A; Lietman TM
    JAMA; 2024 Feb; 331(6):482-490. PubMed ID: 38349371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive insecticide spraying for fly control after mass antibiotic treatment for trachoma in a hyperendemic setting: a randomised trial.
    West SK; Emerson PM; Mkocha H; McHiwa W; Munoz B; Bailey R; Mabey D
    Lancet; 2006 Aug; 368(9535):596-600. PubMed ID: 16905024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial.
    Arzika AM; Maliki R; Boubacar N; Kane S; Cotter SY; Lebas E; Cook C; Bailey RL; West SK; Rosenthal PJ; Porco TC; Lietman TM; Keenan JD;
    PLoS Med; 2019 Jun; 16(6):e1002835. PubMed ID: 31237871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
    Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Melak B; Chanyalew M; Tadesse Z; Callahan EK; Nash SD
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006270. PubMed ID: 29451881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.